Skip to main content
Watch Insiders

Corporate insider profile

Sushil Patel Insider Trades

Latest reported as Chief Executive Officer of Replimune Group, Inc. (REPL).

Purchase filings
0
Reported companies
2
Net open-market value
-$1,748,826.15
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

REPLLatest reported

Replimune Group, Inc.

Chief Executive Officer

RVMDPrior filing

Revolution Medicines, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026Replimune Group, Inc. (REPL)Chief Executive OfficerSale39,341$12.97$510,253
Jun 29, 2026Revolution Medicines, Inc. (RVMD)DirectorSale5,580$187.99$1,048,967
May 18, 2026Replimune Group, Inc. (REPL)Chief Executive OfficerSale37,324$5.08$189,606